Lymphatic endothelial cells - key players in regulation of tolerance and immunity

The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate, and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory mo...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 3; p. 305
Main Authors Tewalt, Eric F., Cohen, Jarish N., Rouhani, Sherin J., Engelhard, Victor H.
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Research Foundation 01.01.2012
Frontiers Media S.A
Subjects
Online AccessGet full text
ISSN1664-3224
1664-3224
DOI10.3389/fimmu.2012.00305

Cover

More Information
Summary:The lymphatic vasculature provides routes for dendritic cell and lymphocyte migration into and out of lymph nodes. Lymphatic endothelial cells (LEC) control these processes by expression of CCL21, sphingosine-1-phosphate, and adhesion molecules. LEC express MHC-I and MHC-II, but not costimulatory molecules, and present antigen on MHC-I via both direct and cross-presentation. Whether LEC present to CD4 T cells on MHC-II is unknown. Interestingly, LEC express antigens otherwise restricted to a small number of peripheral tissues in an autoimmune regulatory element-independent manner. Direct presentation of peripheral tissue antigens (PTA) to CD8 T cells results in abortive proliferation and deletion, due to both a lack of costimulation and active PD-L1 engagement. Autoimmunity develops when deletion is subverted, suggesting that LEC presentation of PTA could lead to human disease if PD-1 signaling were impaired by genetic polymorphisms, or aberrant costimulation occurred during inflammation. The expression of additional inhibitory molecules, which are not involved in LEC-mediated deletion, suggests that LEC may have additional immunoregulatory roles. LEC express receptors for several immunomodulatory molecules whose engagement alters their phenotype and function. In this review we describe the role of LEC in distinct anatomical locations in controlling immune cell trafficking, as well as their emerging role in the regulation of T cell tolerance and immunity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Edited by: Christopher G. Mueller, Centre National de la Recherche Scientifique, France
This article was submitted to Frontiers in Antigen Presenting Cell Biology, a specialty of Frontiers in Immunology
Reviewed by: Melody A. Swartz, Ecole Polytechnique Fédérale de Lausanne, Switzerland; Theresa T. Lu, Hospital for Special Surgery/Weill Cornell Medical Center, USA; Christopher G. Mueller, Centre National de la Recherche Scientifique, France
Eric F. Tewalt, Jarish N. Cohen, and Sherin J. Rouhani have contributed equally to this work.
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2012.00305